Cargando…
All coffee types decrease the risk of adverse clinical outcomes in chronic liver disease: a UK Biobank study
BACKGROUND: Chronic liver disease (CLD) is a growing cause of morbidity and mortality worldwide, particularly in low to middle-income countries with high disease burden and limited treatment availability. Coffee consumption has been linked with lower rates of CLD, but little is known about the effec...
Autores principales: | Kennedy, Oliver J., Fallowfield, Jonathan A., Poole, Robin, Hayes, Peter C., Parkes, Julie, Roderick, Paul J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8218514/ https://www.ncbi.nlm.nih.gov/pubmed/34154561 http://dx.doi.org/10.1186/s12889-021-10991-7 |
Ejemplares similares
-
Coffee consumption and health: umbrella review of meta-analyses of multiple health outcomes
por: Poole, Robin, et al.
Publicado: (2017) -
Misclassification of coffee consumption data and the development of a standardised coffee unit measure
por: Poole, Robin, et al.
Publicado: (2019) -
Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose–response meta-analysis
por: Kennedy, Oliver John, et al.
Publicado: (2017) -
The impact of non-alcoholic fatty liver disease and liver fibrosis on adverse clinical outcomes and mortality in patients with chronic kidney disease: a prospective cohort study using the UK Biobank
por: Hydes, Theresa J., et al.
Publicado: (2023) -
Associations of coffee genetic risk scores with consumption of coffee, tea and other beverages in the UK Biobank
por: Taylor, Amy E., et al.
Publicado: (2017)